Estamos no ar no ! Saiba mais
ícone de HUMAW

Humacyte Inc Warrant
HUMAW

Deslistada

HUMAW foi retirado da bolsa em 25 de agosto de 2026.

 

Sobre: Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Funcionários: 184

Notícias

Positiva
Neutra
Negativa
Sentimento 3 meses
Positiva 0%
Neutra 0%
Negativa 0%
Gráficos de preços implementados com Lightweight Charts™